Expression of carbonic anhydrase IX in breast is associated with malignant tissues and is related to overexpression of c-erbB2

Journal of Pathology

Volumn 197, Issue 3, 2002, Pages 314-321

  Bartoov, Mria ^a   Parkkila, Seppo ^a   Pohlodek, Kamil ^b   Karttunen, Tuomo J ^b   Galbav, Tefan ^c   Mucha, Vojtech ^c   Harris, Adrian L ^c   Pastorek, Jaromr ^b   Pastorekov, Silvia ^d  

^a INSTITUTE OF VIROLOGY   (Slovakia)

^b Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^c UNIVERSITY OF OULU   (Finland)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Breast carcinogenesis; c erbB2; Carbonic anhydrase IX; Immunohistochemistry; Semiquantitative RT PCR

Indexed keywords

CARBONATE DEHYDRATASE; ESTROGEN RECEPTOR; HERMES ANTIGEN; ONCOPROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CELL COMMUNICATION; CELL MEMBRANE; CONTROLLED STUDY; EPITHELIUM CELL; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; ANTIGENS, NEOPLASM; BREAST; BREAST NEOPLASMS; CARBONIC ANHYDRASES; CHI-SQUARE DISTRIBUTION; FEMALE; GENES, ERBB-2; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM PROTEINS; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 0036069159     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1120     Document Type: Article

References (34)

1. Cloning and characterization of MN, a human tumour-associated protein with a domain homologous to carbonic anhydrase and putative helix-loop-helix DNA binding segment
2. Human MNICA9 gene, a novel member of the carbonic anhydrase family: Structure and exon to protein domain relationships
3. Expression of MaTu-MN protein in human tumour cultures and in clinical specimens
4. Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild type von Hippel-Lindau transgenes
5. Carbonic anhydrase IX, MN/CA IX: Analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts
6. Immunohistochemistry of carbonic anhydrase isozyme IX (MN/CA IX) in human gut reveals polarized expression in the epithelial cells with the highest proliferative capacity
7. Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas
8. Expression of the MN antigen in cervical Papanicolaou smears is an early diagnostic biomarker of cervical dysplasia
9. Expression of MN/CA9 protein in Papanicolau smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia
10. Expression of the tumour-associated gene MN: A potential biomarker for human renal cell carcinoma
11. MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas
12. MN antigen expression in normal, preneoplastic, and neoplastic esophagus: A clinicopathological study of a new cancer-associated biomarker
13. Carbonic anhydrase IX antigen differentiates between preneoplastic and malignant lesions in non-small cell lung carcinoma
14. Immunohistochemical study of colorectal tumours for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation
15. Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro
16. Hypoxia-inducible expression of tumor-associated carbonic anhydrases
17. Study of in vitro conditions modulating expression of MN/CA IX protein in human cell lines derived from cervical carcinoma
18. Human tumour-associated cell adhesion protein MN/CA IX: Identification of M75 epitope and of binding site for the cells
19. MN/CA9 gene expression as a potentiial biomarker in renal cell carcinoma
20. The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9
21. Histological typing of breast tumours
22. Estrogen receptors in breast cancer therapy
23. ERBB2 oncogene in human breast cancer and its clinical significance
24. c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer
25. CD44 variant epitopes in primary breast cancer and length of survival
26. Molecular alterations in breast cancer
27. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney
28. Stromal-epithelial cell interactions in breast cancer
29. Keratinocytes can regulate prostaglandin synthesis by fibroblasts: Potential role for interleukin 1
30. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: Implications for tumuorigenesis
31. The molecular basis of the hypoxia response pathway: Tumour hypoxia as a therapy target
32. Neutralizing antibodies against epidermal growth factor and erbb2/neu receptor tyrosine kinases down-regulate vascular endothelial growth implications for signal transduction therapy of solid tumours
33. Breast cancer. ASCO 2001: Critical Commentaries
34. A carbonic anhydrase inhibitor as a potential modulator of cancer therapies